Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease

By Iikuni Noriko   Kitahama Mariko   Ohta Shuji   Okamoto Hiroshi   Kamatani Naoyuki   Nishinarita Makoto  

Modern Rheumatology, Vol. 16, Iss. 5, 2006-10 ,pp. : 282-288

Springer Publishing Company

Access to resources Recommend Favorite

Has the Time Come for Routine Trimethoprim-Sulfamethoxazole Prophylaxis in Patients Taking Biologic Therapies?

By Snydman David R.   Bodro Marta   Paterson David L.  

Clinical Infectious Diseases, Vol. 56, Iss. 11, 2013-06 ,pp. : 1621-1628

Oxford University Press

Access to resources Recommend Favorite

Evaluation of the current management protocols for prophylaxis against Pneumocystis jiroveci pneumonia and other opportunistic infections in patients living with HIV/AIDS

By Jain Sheel Bhadra   Wig Naveet   Nagpal Sajan Jiv Singh   Mishra Nitin   Vajpayee Madhu   Guleria Randeep   Pandey Ravindra Mohan   Sharma Surendra K.  

AIDS Care, Vol. 23, Iss. 7, 2011-07 ,pp. : 846-850

Routledge Ltd

Access to resources Recommend Favorite

Differences and similarities of cytomegalovirus and pneumocystis pneumonia in HIV-negative immunocompromised patients – thin section CT morphology in the early phase of the disease

By Vogel M N   Brodoefel H   Hierl T   Beck R   Bethge W A   Claussen C D   Horger M S  

British Journal of Radiology, Vol. 80, Iss. 955, 2007-07 ,pp. : 516-523

British Institute of Radiology

Access to resources Recommend Favorite

Pneumocystis jiroveci Pneumonia in Adult Patients with AIDS: Treatment Strategies and Emerging Challenges to Antimicrobial Therapy

By Patel Naimish   Koziel Henry  

Treatments in Respiratory Medicine, Vol. 3, Iss. 6, 2004-01 ,pp. : 381-397

Adis International

Access to resources Recommend Favorite